Osteoporosis during androgen deprivation therapy for prostate cancer
- 1 September 2002
- Vol. 60 (3) , 79-85
- https://doi.org/10.1016/s0090-4295(02)01579-0
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- INCIDENCE OF SKELETAL COMPLICATIONS IN PATIENTS WITH BONE METASTATIC PROSTATE CANCER AND HORMONE REFRACTORY DISEASE: PREDICTIVE ROLE OF BONE RESORPTION AND FORMATION MARKERS EVALUATED AT BASELINEJournal of Urology, 2000
- Alendronate for the Treatment of Osteoporosis in MenNew England Journal of Medicine, 2000
- Estrogen Receptor Gene Polymorphism, But Not Estradiol Levels, Is Related to Bone Density in Healthy Adolescent Boys: A Cross-Sectional and Longitudinal StudyJournal of Clinical Endocrinology & Metabolism, 1999
- BONE MINERAL DENSITY IN MEN TREATED WITH SYNTHETIC GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PROSTATIC CARCINOMAJournal of Urology, 1999
- Comparative Tolerability of Drug Therapies for Hypercalcaemia of MalignancyDrug Safety, 1999
- The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinomaCancer, 1998
- Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable EstrogenJournal of Clinical Endocrinology & Metabolism, 1998
- Osteoporosis After Orchiectomy for Prostate CancerJournal of Urology, 1997
- A longitudinal evaluation of bone mineral density in adult men with histories of delayed pubertyJournal of Clinical Endocrinology & Metabolism, 1996
- A comparison of lateral versus anterior-posterior spine dual energy x- ray absorptiometry for the diagnosis of osteopeniaJournal of Clinical Endocrinology & Metabolism, 1994